Growth Factor Group, Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford, UK.
Biochem J. 2013 Jan 15;449(2):389-400. doi: 10.1042/BJ20120972.
Hypoxia in the microenvironment of many solid tumours is an important determinant of malignant progression. The ISR (integrated stress response) protects cells from the ER (endoplasmic reticulum) stress caused by severe hypoxia. Likewise, autophagy is a mechanism by which cancer cells can evade hypoxic cell death. In the present paper we report that the autophagy-initiating kinase ULK1 (UNC51-like kinase 1) is a direct transcriptional target of ATF4 (activating transcription factor 4), which drives the expression of ULK1 mRNA and protein in severe hypoxia and ER stress. We demonstrate that ULK1 is required for autophagy in severe hypoxia and that ablation of ULK1 causes caspase-3/7-independent cell death. Furthermore, we report that ULK1 expression is associated with a poor prognosis in breast cancer. Collectively, the findings of the present study identify transcriptional up-regulation of ULK1 as a novel arm of the ISR, and suggest ULK1 as a potentially effective target for cancer therapy.
许多实体瘤微环境中的缺氧是恶性进展的重要决定因素。ISR(综合应激反应)可保护细胞免受严重缺氧引起的内质网应激。同样,自噬是癌细胞逃避缺氧细胞死亡的一种机制。在本文中,我们报告说,自噬起始激酶 ULK1(UNC51 样激酶 1)是 ATF4(激活转录因子 4)的直接转录靶标,ATF4 在严重缺氧和内质网应激时驱动 ULK1 mRNA 和蛋白的表达。我们证明 ULK1 是严重缺氧时自噬所必需的,并且 ULK1 的缺失会导致 caspase-3/7 非依赖性细胞死亡。此外,我们报告说 ULK1 的表达与乳腺癌的不良预后相关。总之,本研究的结果确定了 ULK1 的转录上调是 ISR 的一个新分支,并表明 ULK1 是癌症治疗的一个潜在有效靶点。